GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Additional Paid-In Capital

CurveBeam AI (ASX:CVB) Additional Paid-In Capital : A$0.00 Mil(As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Additional Paid-In Capital?



CurveBeam AI Additional Paid-In Capital Historical Data

The historical data trend for CurveBeam AI's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Additional Paid-In Capital Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23
Additional Paid-In Capital
- - -

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23
Additional Paid-In Capital - - - - -

CurveBeam AI Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

CurveBeam AI Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


CurveBeam AI (ASX:CVB) Business Description

Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines